Further studies demonstrated that TCSG from Baishouwu suppressed the development of hepatic and renal fibrosis through inhibiting MyD88 signal transduction activated by IL-1β and subsequent p38 MAPK and NF-κB p65 downstream signaling. The gene discussed is NFKB1; the disease is renal fibrosis.